（二）代表性论文

1.Chen Z，Brand NJ，Chen A，Chen SJ，Tong JH，Wang ZY，Waxman S，Zelent A.Fusion between a novel Kruppel-like zinc finger gene and the retinoic acid receptora locus due to a variant t（11；17）translocation associated with acute promyelocytic leukemia.EMBO J，1993（12）：1161-1167.

2.Chen GQ，Zhu J，Shi XG，Ni JH，Zhong HJ，Si GY，Jin XL，Tang W，Li XS，Xiong SM，Shen ZX，Ma J，Zhang P，Zhang TD，Gazin C，Naoe T，Chen SJ，Wang ZY，Chen Z.In vitro studies on cellular and molecular mechanisms of arsenic trioxide（As2 O3）in the treatment of acute promyelocytic leukemia：As2 O 3 induces NB4 cell apoptosis with down-regulation of Bcl-2 expression and alteration of PML-RARa/PML protein localization.Blood，1996（88）：1052-1061.

3.Shen ZX，Chen GQ，Ni JH，Li XS，Xiong SM，Qiu QY，Zhu J，Tang W，Sun GL，Yang KQ，Chen Y，Zhou L，Fang ZW，Wang YT，Ma J，Zhang P，Zhang TD，Chen SJ，Chen Z，Wang ZY.Use of arsenic trioxide （As2 O3）in the treatment of acute promyelocytic leukemia （APL）：II.Clinical efficacy and pharmacokinetics in relapsed patients.Blood，1997（89）：3354-3360.

4.Niu C，Yan H，Yu T，Sun HP，Liu JX，Li XS，Wu W，Zhang FQ，Chen Y，Zhou L，Li JM，Zeng XY，Ou Yang RR，Yuan MM，Ren MY，Gu FY，Gu BW，Cao Q，Su XY，Chen GQ，Xiong SM，Zhang TD，Samuel W，Wang ZY，Chen Z，Hu J，Shen ZX，Chen SJ.Studies on treatment of acute promyelocytic leukemia with arsenic trioxide：remission induction，follow-up and molecular monitoring in 11 newly diagnosed and 47 relapsed acute promyelocytic leukemia patients.Blood，1999（94）：3315-3324.

5.Du YZ，Wang KK，Fang H，Li JM，Xiao DK，Zheng PZ，Chen YL，Fan HY，Zhao CJ，Zhang QH，Fang J，Auffray C，Chen SJ，Chen Z，Zhang J.Coordination of intrinsic，extrinsic and endoplasmic reticulum-mediated apoptosis by imatinib mesylate combined with arsenic trioxide in chronic myeloid leukemia.Blood，2006（107）：1582-1590.

6.Wang L，Zhou GB，Liu P，Song JH，Liang Y，Yang XJ，Xu F，Wang BS，Mao JH，Shen ZY，Chen SJ，Chen Z.Dissection of mechanisms of Chinese medicinal formula Realgar-Indigo naturalis as an effective treatment for promyelocytic leukemia.Proc Natl Acid Sci USA，2008（105）：4826-4831.

7.Hu J，Liu YF，Wu CF，Xu F，Shen ZX，Zhu YM，Li JM，Tang W，Zhao WL，Wu W，Sun HP，Chen QS，Chen B，Zhou GB，Zelent A，Waxman S，Wang ZY，Chen SJ，Chen Z.Long-term efficacy and safety of all-trans retinoic acid/arsenic trioxide based therapy in newly diagnosed acute promyelocytic leukemia.Proc Natl Acad Sci USA，2009（106）：3342-3347.

8.Zhang XW，Yan XJ，Yang FF，Zhou ZR，Wu ZY，Sun HB，Liang WX，Song AX，Huang QH，Zhou GB，Tong JH，Zhang Y，Wu JH，Hu HY，de ThéH，Chen SJ，Chen Z.Arsenic trioxide controls the fate of the PML-RARα oncoprotein by directly binding PML.Science，2010（328）：240-243.

9.Wang KK，Wang P，Shi JT，Zhu XH，He MM，Jia XH，Yang XW，Qiu F，Jin W，QianMX，Fang H，Mi JQ，Yang XZ，Xiao HS，Minder M，Du YZ，Chen Z，Zhang J.PML/RARalpha targets promoterregionscontaining PU.1consensus and RARE half sites in acute promyelocyticleukemia.Cancer Cell，2010（17）：186-197.

10.Li XY，Jiang LJ，Chen L，Ding ML，Guo ZH，Zhang W，Zhang HX，Ma XD，Liu XZ，XiXD，Chen SJ，Chen Z，Zhu J.RIG-I modulates Src-mediated AKT activation to restrain leukemic stemness.Molecular Cell，2014（53）：407-419.